Baker McKenzie advised Ariceum Therapeutics on the deal. Ariceum Therapeutics (Ariceum) completed a EUR 25 million Series A financing round, co-led by EQT Life Sciences (formerly LSP)...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here